Marble Wealth LLC Invests $957,000 in Intuitive Surgical, Inc. $ISRG

Marble Wealth LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, Holdings Channel reports. The institutional investor bought 1,689 shares of the medical equipment provider’s stock, valued at approximately $957,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Newbridge Financial Services Group Inc. increased its stake in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares in the last quarter. Holos Integrated Wealth LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Olistico Wealth LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Laurel Wealth Advisors LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $31,000. Finally, Turning Point Benefit Group Inc. increased its stake in shares of Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the company’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the sale, the director directly owned 120 shares in the company, valued at $55,620. This represents a 49.79% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 8,096 shares of company stock valued at $3,545,294. Insiders own 0.60% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Negative Sentiment: Deutsche Bank cut its price target on Intuitive Surgical (ISRG) to $366 from $440 and kept a sell rating, reinforcing concerns that the stock may have further downside from current levels. MarketScreener article
• Negative Sentiment: Company SVP Iman Jeddi sold 5,625 shares in a pre-arranged 10b5-1 plan, a transaction that can still weigh on sentiment because it reduces insider ownership and may signal caution to some investors.
• Neutral Sentiment: Several articles highlighted that ISRG is a highly watched and frequently traded name, but these pieces were mostly informational and did not present a new catalyst. Zacks article
• Neutral Sentiment: Analysts and commentary also pointed to Intuitive Surgical’s AI-driven digital roadmap and connected da Vinci ecosystem as a potential long-term growth driver, but that story appears to be offset today by valuation and rating concerns. Yahoo Finance article

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $402.30 on Wednesday. The firm’s 50 day moving average price is $452.19 and its 200-day moving average price is $504.81. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88. The firm has a market cap of $142.48 billion, a P/E ratio of 48.76, a P/E/G ratio of 3.29 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same period in the prior year, the firm earned $1.81 EPS. The firm’s revenue for the quarter was up 23.0% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on ISRG shares. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Sunday, May 24th. Evercore lowered their price target on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research report on Monday, April 6th. Bank of America decreased their target price on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a report on Monday, May 18th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Intuitive Surgical in a report on Tuesday, May 19th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $573.63.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.